The Deciphering Developmental Disorders (DDD) study is an ambitious project combining the clinical expertise of all 23 UK NHS Regional Genetics Services with the research and bioinformatics expertise of the Wellcome Trust Sanger Institute, to undertake systematic phenotyping and detailed genomic analysis for 12 000 children with severe undiagnosed developmental disorders. The Deciphering Developmental Disorders (DDD) Study has recruited nearly 14,000 children with severe undiagnosed developmental disorders and their parents from around the UK and Ireland.
The study recruits trios (a child and both parents) and aims to identify de novo variants in the child and identify relevant recessive mutations.
DNA extraction is done from saliva samples.
Samples were collected at the Wellcome Sanger Institute.
Complementary genome-wide approaches are then used: high resolution array-comparative genomic hybridization (aCGH), common variant (SNP) genotyping, and whole exome sequencing.
The patients have been deeply phenotyped by their referring clinican via DECIPHER using the Human Phenotype Ontology.
Likely diagnostic results are being reported to clinical teams.
- 10.1111/j.1469-8749.2011.04032.x: Firth, H. V., Wright, C. F., & DDD Study. The Deciphering Developmental Disorders (DDD) study. Dev. Med. Child Neurol. 53, 702–703 (2011).